Skip to main content

Table 1 Changes on MRI after ESWT compared to no ESWT

From: The use of extracorporeal shock wave therapy for the treatment of bone marrow oedema — a systematic review and meta-analysis

Study ESWT No ESWT Between group difference
Gao et al. [1] After 6 months:
Reduction in 35%
Complete regression in 65%
After 12 months:
Complete regression in 100%
After 6 months:
Reduction in 40%
Complete regression in 25%
After 12 months:
Complete regression in 90%
Significant superiority of ESWT after 6 months (p = 0.018)
Schöberl et al. [17] After 3 months:
Grading 1.5
After 3 months:
Grading 1.5
n.s.
Kang et al. [4] After 3 months:
Reduction in 90.2% of patients
After 6 months:
Reduction in 95.1% of patients
After 12 months:
Reduction in 100% of patients
After 3 months:
Reduction in 61.4% of patients
After 6 months:
Reduction in 79.5% of patients
After 12 months:
Reduction in 97.7% of patients
After 3 months:
Significant superiority of ESWT (p < 0.001)
After 6 months:
Significant superiority of ESWT (p = 0.006)
After 12 months:
n.s.
Sansone et al. [6] After 6 months:
88% reduction
After 6 months:
41% reduction
Significant superiority of ESWT after 6 months (p < 0.001)
Vitali et al. [3] After 4 months:
77% reduction
After 4 months:
40% reduction
Significant superiority of ESWT after 6 months (p < 0.00001)
  1. ESWT extracorporeal shock wave therapy, n.s. not significant